PROVIDENCE, R.I., Oct. 2, 2019 /PRNewswire/ -- Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation.  Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Map

HOLON, Israel, Oct. 2, 2019 /PRNewswire/ -- October 2, 2019 – Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced it will present three posters at the

LANDING, New Jersey, Oct. 2, 2019 /PRNewswire/ -- DolCas Biotech, LLC, launches Bergacyn®, a clean-label powerhouse blend of botanical extracts derived from the Italian bergamot citrus fruit (Citrus bergamia) and the wild-crafted Italian artichoke thistle leaf (Cynara cardunculus

REHOVOT, Israel, Oct. 2, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) and (TASE: EVGN), announces today the initiation of pre-clinical studies for BMC321 & BMC322, two rationally-designed microbial consortia aimed to reduce inflammatio

SUNNYVALE, Calif., Oct. 2, 2019 /PRNewswire/ -- Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration for Xpert BCR-ABL Ultra for monitoring disease burden in patients with Chronic Myeloid Leukemia (CML). Xpert BCR-ABL Ultra, an in vitro diagnostic test, is the first FDA-cleared test of its kind capable of deliverin

SAN FRANCISCO, Oct. 2, 2019 /PRNewswire/ --CORA Health Services, Inc., doing business as CORA Physical Therapy ("CORA" or "the Company"), a top-10 national operator of outpatient physical therapy services, announced today that it has broadened its coverage in Virginia with the acquisition of Blacksburg Physical Therapy Associates, Inc. ("

ROCKVILLE, Md., Oct. 2, 2019 /PRNewswire/ -- The U.S. Agency for International Development (USAID) has awarded a 5-year, $160 million cooperative agreement to the United States Pharmacopeia (USP) to sustainably strengthen medical product quality assurance systems in low- and middle-income countries, addressing the

SALT LAKE CITY, Oct. 2, 2019 /PRNewswire/ -- The Myeloma Crowd™, a division of the CrowdCare Foundation, today announced the launch of a new study to identify correlations between psoriasis and multiple myeloma. Psoriasis is an auto-immune disease of the skin and multiple myeloma is a rare blood cancer in which the cancer has escaped the immune system.

LIBERTYVILLE, Ill., Oct. 2, 2019 /PRNewswire/ -- Hollister Incorporated, an independent, employee-owned company that develops, manufactures, and markets healthcare products worldwide, today, announced the official grand opening of its new manufacturing facility in Kaunas, Lithuania, located in the Kaunas FEZ region. The construction

LAVAL, QC, Oct. 2, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce that it is actively pursuing a product development collaboration with International Flavors & Fragrances Inc. (NYSE: IFF) to co-develop hemp-derived CBD products for the U.S. market.